WebDec 4, 2024 · Payne et al. (2024) reported that human BTN3A1 inhibited tumor-reactive alpha-beta T-cell receptor activation by preventing segregation of N-glycosylated CD45 … WebJan 27, 2024 · Here, we report that the butyrophilin BTN3A1 inhibits tumor-reactive αβ T cell receptor activation by preventing segregation of N-glycosylated CD45 from the immune synapse.
LSECtin on tumor-associated macrophages enhances …
WebAug 21, 2024 · The butyrophilin BTN3A1 inhibits tumor-reactive αβ T cell receptor activation by preventing segregation of N-glycosylated CD45 from the immune synapse and may present a treatment strategy for tumors resistant to existing immunotherapies. BTN3A1 governs antitumor responses T lymphocytes are immune cells that can be activated … WebOct 20, 2024 · Three BTN3A isoforms have been described, BTN3A1, BTN3A2, and BTN3A3, which are expressed in humans and NHPs but not in rodents . The ectodomains of all three isoforms are highly similar … the compass madison
Science 免疫治疗的曙光—BTN3A1通过协调αβ T和γδ T细胞调控 …
WebAug 21, 2024 · Here, we report that the butyrophilin BTN3A1 inhibits tumor-reactive αβ T cell receptor activation by preventing segregation of N-glycosylated CD45 from the … WebJan 22, 2024 · BTN3A molecules—BTN3A1 in particular—emerged as important mediators of Vγ9Vδ2 T cell activation by phosphoantigens. These metabolites can originate from infections, e.g. with Mycobacterium tuberculosis, or by alterations in cellular metabolism. the compass institute